Medroxyprogesterone combined with Provera

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Breast Cancer Other Serious 8/6/2002 61 Female 10/4/2005 United States
Primary
Secondary
Breast Cancer Female Other Serious 10/1/1999 Female 1/3/2006 Lawyer United States
Primary
Secondary
Lymphoedema Other Serious Female 1/5/2006 United States
Primary
Secondary
Pain Other Serious Female 1/10/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 12/15/1999 Female 1/11/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 2/10/2004 Female 1/12/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 1/7/2000 Female 1/16/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 1/27/2003 Female 1/18/2006 United States
Primary
Secondary
Oestrogen Receptor Assay Positive Other Serious 1/1/1996 Female 1/20/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 1/1/1996 Female 1/20/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 1/1/1997 Female 1/20/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 1/1/1994 Female 1/20/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 1/1/1994 Female 1/20/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 1/1/1997 Female 1/20/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 3/21/2000 61 Female 1/20/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 2/8/2000 Female 1/23/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 2/1/2002 Female 1/24/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 2/1/2006 United States
Primary
Secondary
Weight Decreased Other Serious 1/1/1997 51 Female 123 lb 2/1/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Metastatic Other Serious 1/1/2001 Female 2/1/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Death 1/1/1997 Female 2/1/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 10/3/2003 69 Female 160 lb 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 9/1/2001 54 Female 120 lb 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 12/1/1999 67 Female 185 lb 12/23/2005 United States
Primary
Secondary
Concomitant
Ovarian Cancer Other Serious 8/9/2001 58 Female 120 lb 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 10/16/2001 49 Female 125 lb 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/1998 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/1998 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 6/1/2003 63 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2000 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 5/1/2003 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 10/25/1999 60 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/7/2003 62 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 2/3/2006 United States
Primary
Secondary
Breast Cancer Other Serious 2/12/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 3/9/2004 58 Female 12/23/2005 United States
Primary
Secondary
Drug Ineffective Other Serious 1/25/2002 57 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/31/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 3/1/1999 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 2/6/2006 United States
Primary
Secondary
Breast Cancer Other Serious 10/4/2002 Female 12/23/2005 United States
Primary
Secondary
Concomitant
Progesterone Receptor Assay Positive Other Serious 2/25/1992 69 Female 2/8/2006 United States
Primary
Secondary
Breast Cancer Other Serious 12/1/2002 Female 12/23/2005 United States
Primary
Secondary
Pulmonary Embolism Other Serious 1/1/1994 Female 12/23/2005 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 2/25/1992 69 Female 2/10/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 2/26/2003 Female 2/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 6/1/1998 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 12/16/1999 Female 12/23/2005 United States
Primary
Secondary
Ovarian Cancer Other Serious 10/1/2001 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 2/28/2000 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Hospitalization 4/1/2003 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 12/3/2003 56 Female 180 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 12/21/2001 60 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 5/1/2003 57 Female 12/23/2005 United States
Primary
Secondary
Cerebrovascular Accident Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 4/1/2003 59 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 9/17/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/29/2003 Female 12/23/2005 United States
Primary
Secondary
Weight Increased Other Serious 1/30/2003 66 Female 2/15/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 12/1/1982 Female 12/23/2005 United States
Primary
Secondary
Thrombosis Other Serious 8/1/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 8/2/2000 64 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 7/10/2002 58 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 10/1/1999 55 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2000 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 7/1/2003 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 6/1/2000 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 12/28/2000 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/7/2003 47 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 6/23/2003 64 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/13/2004 68 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 5/20/2003 65 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 4/1/1999 67 Female 140 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 2/14/2006 United States
Primary
Secondary
Breast Cancer Metastatic Other Serious Female 2/14/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 2/14/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 1/24/2000 Female 2/22/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 10/1/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 9/26/2001 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 5/11/1999 56 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 5/30/2000 58 Female 120 lb 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 9/22/2002 61 Female 140 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 8/16/2000 58 Female 160 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 9/18/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 8/8/2003 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer In Situ Other Serious 1/8/2002 69 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 4/4/2000 59 Female 140 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/7/2000 Female 2/17/2006 United States
Primary
Secondary
Breast Cancer In Situ Other Serious 7/5/2000 59 Female 2/28/2006 Consumer United States
Primary
Secondary
Metastases To Spine Death Female 2/28/2006 United States
Primary
Secondary
Metastases To Peripheral Vascular System Other Serious Female 2/28/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 1/31/2002 Female 3/2/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 1/24/2000 Female 3/2/2006 United States
Primary
Secondary
Breast Cancer Other Serious 2/1/2004 Female 3/7/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 3/3/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 3/21/2002 Female 3/6/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 2/22/1999 78 Female 3/6/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 3/29/2002 Female 3/8/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 9/1/2002 64 Female 160 lb 3/8/2006 United States
Primary
Secondary
Breast Cancer Other Serious 12/10/2001 61 Female 143 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 2/13/2002 Female 140 lb 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 12/1/1999 62 Female 185 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 9/1/2001 63 Female 158 lb 12/23/2005 United States
Primary
Secondary
Weight Increased Other Serious 4/1/2002 48 Female 180 lb 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 6/6/2000 60 Female 165 lb 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 11/1/1999 72 Female 230 lb 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Tenderness Other Serious 9/1/2003 61 Female 182 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 6/1/2000 52 Female 150 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/15/1999 64 Female 12/23/2005 United States
Primary
Secondary
Scar Other Serious 10/1/2003 61 Female 103 lb 3/10/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 2/24/2004 Female 3/13/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 5/15/2000 65 Female 3/15/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 4/22/2002 58 Female 3/15/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 8/29/2000 68 Female 3/17/2006 United States
Primary
Secondary
Oestrogen Receptor Assay Positive Other Serious 7/9/1998 71 Female 3/17/2006 United States
Primary
Secondary
Breast Cancer In Situ Other Serious 5/7/1999 67 Female 3/17/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 3/13/2001 80 Female 3/28/2006 United States
Primary
Secondary
Vomiting Other Serious 1/3/2000 52 Female 190 lb 3/31/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 2/10/1999 80 Female 3/30/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/2/2001 64 Female 4/11/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 6/1/2001 Female 4/5/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 3/15/2002 Female 4/5/2006 United States
Primary
Secondary
Wound Infection Staphylococcal Other Serious 1/30/2003 66 Female 4/14/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 1/7/2003 47 Female 2/9/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 10/4/2002 Female 2/8/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 7/1/2001 Female 4/10/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 4/1/2004 55 Female 4/12/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/12/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 5/30/2003 55 Female 4/13/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 7/3/2002 63 Female 4/13/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 12/21/2001 57 Female 4/13/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 4/12/2004 66 Female 4/20/2006 United States
Primary
Secondary

Drug Data